Equity · Healthcare
IOVA
NASDAQIovance Biotherapeutics (IOVA)
The line runs 6.39 USD on 10 August through 8.04 USD on 6 November, on a scale from 5 to 20. Days the market did not trade hold the previous close, flat.
- Market cap
- 3.7B USD
- Revenue, year to Dec 2025
- 263.5M USD
- EPS, diluted, year to Dec 2025
- −1.09 USD
- 52-week range
- 1.81 USD – 16.60 USD
- Avg volume
- 1.0M
- Mentions, 30 days
- 20
- Net sentiment
- +0.09
as of Nov 6, 2026
Have Iovance Biotherapeutics (IOVA) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Iovance Biotherapeutics insider bought or sold shares on the open market; all 14 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest Form 4 filing 8 Sep 2026
Buys 0Sells 0Other filings 14
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 08 Sep 2026 | Vogt Frederick GInterim CEO & General Counsel | Option exercise | 15,626 | |
| 08 Sep 2026 | Vogt Frederick GInterim CEO & General Counsel | Tax withheld | 6,638 | 58K USD |
| 08 Sep 2026 | BILINSKY IGORChief Operating Officer | Option exercise | 7,813 | |
| 08 Sep 2026 | BILINSKY IGORChief Operating Officer | Tax withheld | 3,976 | 35K USD |
| 08 Sep 2026 | Puri Raj K.Chief Regulatory Officer | Option exercise | 9,766 | |
| 08 Sep 2026 | Puri Raj K.Chief Regulatory Officer | Tax withheld | 4,478 | 39K USD |
| 01 Sep 2026 | Vogt Frederick GInterim CEO & General Counsel | Option exercise | 41,669 | |
| 01 Sep 2026 | Vogt Frederick GInterim CEO & General Counsel | Tax withheld | 17,702 | 147K USD |
| 01 Sep 2026 | Puri Raj K.Chief Regulatory Officer | Option exercise | 5,470 | |
| 01 Sep 2026 | Puri Raj K.Chief Regulatory Officer | Tax withheld | 2,508 | 21K USD |
| 01 Sep 2026 | BILINSKY IGORChief Operating Officer | Option exercise | 8,789 | |
| 01 Sep 2026 | BILINSKY IGORChief Operating Officer | Tax withheld | 4,472 | 37K USD |
Showing the 12 most recent of 14 compensation filings in this window. The figures above count all of them.
Which funds hold Iovance Biotherapeutics (IOVA)?
9 of the 45 institutional funds we track reported a Iovance Biotherapeutics position for the quarter ended 30 Jun 2026 — a combined 152.3M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Two Sigma Investments | Added | 19,010,697 | 79.1M USD | +38.9% |
| Millennium Management | Held (±25%) | 8,525,919 | 35.5M USD | −9.4% |
| AQR Capital Management | Added | 3,869,584 | 16.1M USD | +520.0% |
| D. E. Shaw & Co. | Trimmed | 2,143,134 | 8.9M USD | −73.3% |
| Citadel Advisors | Held (±25%) | 2,104,990 | 8.8M USD | −19.4% |
| Balyasny Asset Management | Added | 373,284 | 1.6M USD | +50.1% |
| Tudor Investment Corp | Added | 293,989 | 1.2M USD | +36.1% |
| Man Group | Added | 252,959 | 1.1M USD | +246.1% |
| Marshall Wace | Trimmed | 39,491 | 164K USD | −98.3% |
What has been filed or recorded for Iovance Biotherapeutics (IOVA)?
The filings we hold for Iovance Biotherapeutics, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 316 shares | 5K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 575,562 shares | 7.7M USD notional · 0.127% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 579 shares | 8K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 120,829 shares | 1.7M USD notional · 0.027% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,292 shares | 34K USD notional · 0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 521,568 shares | 7.5M USD notional · 0.115% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.05 USD | |
| 30 Sep 2026 | Financials | Total assets | 991.2M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 812.7M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 234,099 shares | 2.6M USD notional · 0.052% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 1,535 shares | 17K USD notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,672 shares | 37K USD notional · 0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.11 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.19 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.09 USD | |
| 31 Dec 2025 | Financials | Revenue | 263.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −391.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.09 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2026 reported | EPS −0.25 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.33 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.36 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.28 USD |
What is Reddit saying about Iovance Biotherapeutics (IOVA)?
Reddit mentioned IOVA 20 times in the 30 days to 8 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 60% read bullish, 20% bearish and 20% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 20Bullish 60%Bearish 20%Communities 3Against the market +6 points
How do Reddit mentions of Iovance Biotherapeutics (IOVA) compare with its price?
Share ↗
Where Iovance Biotherapeutics (IOVA) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 75% | 15 | +0.04 |
| r/stocks | 20% | 4 | +0.18 |
| r/investing | 5% | 1 | +0.49 |
Moves with Iovance Biotherapeutics (IOVA)
Tickers whose daily Reddit volume rose and fell with Iovance Biotherapeutics (IOVA)'s. Co-discussion, not price.
CART +0.88NOW +0.87CROX +0.86M +0.80RBLX +0.79DASH +0.79
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Iovance Biotherapeutics (IOVA): frequently asked questions
What did Iovance Biotherapeutics shares close at?
Iovance Biotherapeutics closed at 8.04 USD on 6 Nov 2026, up 3.47% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Iovance Biotherapeutics’ market cap?
Iovance Biotherapeutics is worth 3.7B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Iovance Biotherapeutics’ revenue?
Iovance Biotherapeutics reported revenue of 263.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Iovance Biotherapeutics insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Iovance Biotherapeutics insider bought or sold shares on the open market; all 14 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Iovance Biotherapeutics?
9 of the 45 funds we track reported a Iovance Biotherapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Millennium Management and AQR Capital Management. See Funds
When did Iovance Biotherapeutics last report earnings?
Iovance Biotherapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.05 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Iovance Biotherapeutics?
Iovance Biotherapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 20 times over the trailing 30 days. Of the 20 mentions scored for sentiment, 60% read bullish and 20% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings